A Phase 2 Randomized Trial of ELND005, Scyllo-Inositol, in Mild to Moderate Alzheimer Disease
Neurology - United States
doi 10.1212/wnl.0b013e3182309fa5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 14, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)